Promising results from the 1b portion, albeit a bit hard to interpret.
What doesn't quite make sense to me is why only 3 remain on trial, if results were so positive. @vrs37 any thoughts?
Pretty happy with the enrolment rates in 2a.
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-11
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.55M | |||
| Open | High | Low | Value | Volume |
| 7.4¢ | 7.4¢ | 7.0¢ | $8.195K | 113.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3114 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 44232 | 2 |
View Market Depth
| Last trade - 15.44pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.2¢ |
Change
0.000 ( 1.41 %) |
||||
| Open | High | Low | Volume | ||
| 7.2¢ | 7.2¢ | 7.2¢ | 7699 | ||
| Last updated 11.34am 07/06/2024 ? | |||||
| ATX (ASX) Chart |